Novel Method to Measure Telomere Length

Web Published:
Jan 13, 2011
Description:

Background

 

Leukocyte telomere length (LTL) is commonly used as a biomarker of human aging, principally for vascular aging, as expressed in atherosclerosis. Patients with atherosclerosis display a shorter LTL than their peers without the clinical manifestations of the disease.  Relatively short LTLs are also observed in clinical circumstances that heighten the risk for atherosclerosis, including obesity, insulin resistance, sedentary lifestyle and smoking.  In addition, recent studies, including research in same-sex elderly twins, clearly show that in the elderly, short LTL is associated with diminished survival.  Therefore, short LTL might be linked to human longevity.

 

Description of Invention

 

Telomere length measurement techniques that have commonly been used in epidemiological and clinical research include Southern blot analysis of the terminal restriction fragments (TRFs), quantitative pCR (qPCR), and Flow-FISH.  All of these methods suffer from major shortcomings that limit their current use in clinical settings. Southern blots of the TRFs and qPCR have been used more extensively than Flow-FISH to measure LTL.  The Southern blot method  method requires a substantial amount of DNA, is labor intensive, costly, and necessitates a considerable degree of expertise.  The reliability of the qPCR method has been questioned because of possible PCR amplifications of measurement errors and other potential shortcomings.  In addition, several publications have reported the use of the ratio of telomere to alphoid centromere repeats as an index of telomere length.  However, it has been found that the length of alphoid centromeric repeats is highly variable among individuals making this method unreliable.  Thus, there remains a need for an easy, inexpensive and high throughput method to measure telomere length.         

 

Researchers at UMDNJ have developed a novel, potentially high throughout, inexpensive method to measure telomere length that requires minimal DNA and is not PCR based.  The process utilizes common laboratory techniques and therefore requires little expertise.

 

 

Applications

 

·         Method to measure telomere length

·         Method to determine a patient’s risk for atherosclerosis and other aging-related maladies.

 

 

 

Patent Information:
Category(s):
Diagnostics
For Information, Contact:
Norell Hadzimichalis
Licensing Associate
The University of Medicine and Dentistry of New Jersey
norell.hadzimichalis@umdnj.edu
Inventors:
Abraham Aviv
Masayuki Kimura
Keywords:
Biomarkers
© 2013. All Rights Reserved. Powered by Inteum